99 related articles for article (PubMed ID: 26907084)
1. The Relationship Between Plasma Whole Blood Viscosity and Cardiovascular Events in Patients With Chronic Kidney Disease.
Celik T; Yilmaz MI; Balta S; Ozturk C; Unal HU; Aparci M; Karaman M; Demir M; Yildirim AO; Saglam M; Kilic S; Eyileten T; Aydin İ; Iyisoy A
Clin Appl Thromb Hemost; 2017 Sep; 23(6):663-670. PubMed ID: 26907084
[TBL] [Abstract][Full Text] [Related]
2. Endostatin in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events and survival.
Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Gezer M; Taş A; Eyileten T; Guler AK; Aydin İ; Oguz Y; Tarim K; Covic A; Yilmaz MI
Eur J Intern Med; 2016 Sep; 33():81-7. PubMed ID: 27394925
[TBL] [Abstract][Full Text] [Related]
3. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Eyileten T; Gezer M; Verim S; Oguz Y; Vural A; Ortiz A; Johnson RJ; Covic A; Yilmaz MI
Int Urol Nephrol; 2016 Jul; 48(7):1129-36. PubMed ID: 27007614
[TBL] [Abstract][Full Text] [Related]
4. The relationship between IL-10 levels and cardiovascular events in patients with CKD.
Yilmaz MI; Solak Y; Saglam M; Cayci T; Acikel C; Unal HU; Eyileten T; Oguz Y; Sari S; Carrero JJ; Stenvinkel P; Covic A; Kanbay M
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1207-16. PubMed ID: 24789549
[TBL] [Abstract][Full Text] [Related]
5. IL-33 and ST2 levels in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events, and survival.
Gungor O; Unal HU; Guclu A; Gezer M; Eyileten T; Guzel FB; Altunoren O; Erken E; Oguz Y; Kocyigit I; Yilmaz MI
PLoS One; 2017; 12(6):e0178939. PubMed ID: 28614418
[TBL] [Abstract][Full Text] [Related]
6. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients.
Kanbay M; Yilmaz MI; Apetrii M; Saglam M; Yaman H; Unal HU; Gok M; Caglar K; Oguz Y; Yenicesu M; Cetinkaya H; Eyileten T; Acikel C; Vural A; Covic A
Am J Nephrol; 2012; 36(3):228-37. PubMed ID: 22948239
[TBL] [Abstract][Full Text] [Related]
7. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
Sonmez A; Yilmaz MI; Saglam M; Unal HU; Gok M; Cetinkaya H; Karaman M; Haymana C; Eyileten T; Oguz Y; Vural A; Rizzo M; Toth PP
Lipids Health Dis; 2015 Apr; 14():29. PubMed ID: 25885289
[TBL] [Abstract][Full Text] [Related]
8. Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease.
Solak Y; Yilmaz MI; Siriopol D; Saglam M; Unal HU; Yaman H; Gok M; Cetinkaya H; Gaipov A; Eyileten T; Sari S; Yildirim AO; Tonbul HZ; Turk S; Covic A; Kanbay M
Int Urol Nephrol; 2015 Dec; 47(12):1993-2001. PubMed ID: 26498629
[TBL] [Abstract][Full Text] [Related]
9. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease.
Yilmaz MI; Siriopol D; Saglam M; Kurt YG; Unal HU; Eyileten T; Gok M; Cetinkaya H; Oguz Y; Sari S; Vural A; Mititiuc I; Covic A; Kanbay M
Kidney Int; 2014 Dec; 86(6):1213-20. PubMed ID: 24988065
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease.
Solak Y; Yilmaz MI; Sonmez A; Saglam M; Cakir E; Unal HU; Gok M; Caglar K; Oguz Y; Yenicesu M; Karaman M; Ay SA; Gaipov A; Turk S; Vural A; Carrero JJ
Clin Exp Nephrol; 2013 Aug; 17(4):532-40. PubMed ID: 23180042
[TBL] [Abstract][Full Text] [Related]
11. Thyroid function and cardiovascular events in chronic kidney disease patients.
Afsar B; Yilmaz MI; Siriopol D; Unal HU; Saglam M; Karaman M; Gezer M; Sonmez A; Eyileten T; Aydin I; Hamcan S; Oguz Y; Covic A; Kanbay M
J Nephrol; 2017 Apr; 30(2):235-242. PubMed ID: 27039198
[TBL] [Abstract][Full Text] [Related]
12. Mean corpuscular volume is associated with endothelial dysfunction and predicts composite cardiovascular events in patients with chronic kidney disease.
Solak Y; Yilmaz MI; Saglam M; Demirbas S; Verim S; Unal HU; Gaipov A; Oguz Y; Kayrak M; Caglar K; Vural A; Turk S; Covic A; Kanbay M
Nephrology (Carlton); 2013 Nov; 18(11):728-35. PubMed ID: 23848392
[TBL] [Abstract][Full Text] [Related]
13. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients.
Kanbay M; Siriopol D; Saglam M; Kurt YG; Gok M; Cetinkaya H; Karaman M; Unal HU; Oguz Y; Sari S; Eyileten T; Goldsmith D; Vural A; Veisa G; Covic A; Yilmaz MI
J Clin Endocrinol Metab; 2014 Oct; 99(10):E1854-61. PubMed ID: 25057883
[TBL] [Abstract][Full Text] [Related]
14. Association of BP with Death, Cardiovascular Events, and Progression to Chronic Dialysis in Patients with Advanced Kidney Disease.
Palit S; Chonchol M; Cheung AK; Kaufman J; Smits G; Kendrick J
Clin J Am Soc Nephrol; 2015 Jun; 10(6):934-40. PubMed ID: 25979975
[TBL] [Abstract][Full Text] [Related]
15. Effects of Cardiovascular Events on End-Stage Renal Disease and Mortality in Patients With Chronic Kidney Disease Before Dialysis.
Kuwahara M; Takehara E; Sasaki Y; Azetsu H; Kusaka K; Shikuma S; Akita W
Ther Apher Dial; 2016 Feb; 20(1):12-9. PubMed ID: 26679409
[TBL] [Abstract][Full Text] [Related]
16. The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: A prospective cohort study.
Shardlow A; McIntyre NJ; Kolhe NV; Nellums LB; Fluck RJ; McIntyre CW; Taal MW
PLoS Med; 2020 Jul; 17(7):e1003163. PubMed ID: 32658890
[TBL] [Abstract][Full Text] [Related]
17. The association of profilin-1 levels with survival in chronic kidney disease.
Eroglu E; Unal HU; Guclu A; Kocyigit I; Karaman M; Saglam M; Gezer M; Tas A; Zararsiz G; Eyileten T; Aydin İ; Oguz Y; Gungor O; Yilmaz MI
Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 28981140
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin in Chronic Kidney Disease: Associations with Vascular Damage and Cardiovascular Events.
Yilmaz MI; Siriopol D; Saglam M; Unal HU; Karaman M; Gezer M; Kilinc A; Eyileten T; Guler AK; Aydin İ; Vural A; Oguz Y; Covic A; Ortiz A; Kanbay M
Calcif Tissue Int; 2016 Aug; 99(2):121-30. PubMed ID: 27016924
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound.
Valdivielso JM; Betriu A; Martinez-Alonso M; Arroyo D; Bermudez-Lopez M; Fernandez E;
PLoS One; 2017; 12(10):e0186665. PubMed ID: 29045466
[TBL] [Abstract][Full Text] [Related]
20. Impact of cardiovascular events on mortality and progression of renal dysfunction in a Queensland CKD cohort.
Jeyaruban A; Hoy W; Cameron A; Healy H; Wang Z; Zhang J; Mallett A
Nephrology (Carlton); 2020 Nov; 25(11):839-844. PubMed ID: 32536031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
